Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.4 (1.15%) Market Cap: 15.07 Bil Enterprise Value: 18.32 Bil PE Ratio: 31.89 PB Ratio: 2.85 GF Score: 71/100

Q2 2023 Ossur hf Earnings Call Transcript

Jul 25, 2023 / 07:00AM GMT
Release Date Price: kr32.4 (+1.73%)
Operator

Good day, and thank you for standing by. Welcome to the Ossur Q2 2023 Results Conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Sveinn Solvason, President and CEO. Please go ahead, sir.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you all to the Ossur Investor Conference Call where we will cover the results for the second quarter.

My name is Sveinn Solvason, and I'm the President and CEO. And with me here today is Arna Sveinsdottir, our CFO. We'll begin by going through the highlight of the quarter and end with our guidance for '23. A Q&A session will then follow.

If we start by going through the key takeaways, I'm very pleased to report continued strong sales performance across all regions and business segments. The growth was largely driven by volume growth in Prosthetics and Patient Care, as well as favorable

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot